Joe Green

Later-generation fluoroquinolones more effective at reducing mortality risk in resistant TB

Later-generation fluoroquinolones significantly reduced the risk for mortality in patients with suspected drug-resistant tuberculosis compared with early-generation drugs of the same family, according to researchers.

Read More →

Early, intensified TB meningitis treatment decreases mortality risk

Early and intensified medication improved survival in patients with isoniazid-resistant tuberculosis meningitis, according to researchers.

Read More →

TB/HIV outreach finding patients in remote South Africa

A novel tuberculosis and HIV case-finding method effectively detected people with both diseases in a remote area of South Africa, according to researchers.

Read More →

Page 1 of 1 · Total posts: 3